Market Overview The Europe Sickle Cell Disease Treatment Market reached US$ 883.26 million in 2024 and is expected to reach US$ 2,492.84 million by 2033, growing at a CAGR of 15.7% during the forecast period 2025-2033. Sickle cell disease treatment manages symptoms of abnormal hemoglobin, preventing crises and organ damage. Rising cases in Europe spur novel therapies like gene editing. Unmet...